Wilms' tumor suppressor 1 (WT1) plays an important role in cell proliferation and mesenchymal-epithelial balance in normal development and disease. Here, we show that following podocyte depletion in three experimental models, and in patients with focal segmental glomerulosclerosis (FSGS) and membranous nephropathy, WT1 increased significantly in cells of renin lineage (CoRL). In an animal model of FSGS in RenWt1 fl/fl reporter mice with inducible deletion of WT1 in CoRL, CoRL proliferation and migration to the glomerulus was reduced, and glomerular disease was worse compared with wild-type mice. To become podocytes, CoRL undergo mesenchymal-toepithelial transformation (MET), typified by reduced staining for mesenchymal markers (MYH11, SM22, aSMA) and de novo expression of epithelial markers (E-cadherin and cytokeratin18). Evidence for changes in MET markers was barely detected in RenWt1 fl/fl mice.
INTRODUCTION
Kidney podocytes are terminally differentiated glomerular epithelial cells unable to self-renew due to their inability to proliferate (Lasagni et al., 2013; Wanner et al., 2014) , and replacement following loss is dependent on local kidney progenitors (Ronconi et al., 2009; Lasagni et al., 2015; Starke et al., 2015) . Glomerular parietal epithelial cells (PECs) (Romagnani, 2011; Zhang et al., 2013; Eng et al., 2015; Kuppe et al., 2015; Lazzeri and Romagnani, 2015) and cells of renin lineage (CoRL) Lichtnekert et al., 2016) are considered likely adult podocyte progenitors. CoRL serve as progenitors for several kidney cell types (Sequeira Lopez et al., 2004) , including podocytes (Grahammer et al., 2013; Pippin et al., 2013 Pippin et al., , 2014 Pippin et al., , 2015 Shankland et al., 2014; Lichtnekert et al., 2016) , PECs Eng et al., 2015) , mesangial cells (Thoma, 2014; Starke et al., 2015) , and pericytes (Stefanska et al., 2013; Pippin et al., 2015) . RAAS inhibition augments the CoRL reservoir in the juxta-glomerular compartment (JGC) through proliferation, enhances migration to the glomerulus, and increases transdifferentiation toward a podocyte fate (Lichtnekert et al., 2016) . CoRL and podocytes derive from mesenchymal origins (Costantini and Kopan, 2010; Matsushita et al., 2010; Little and McMahon, 2012; Wang et al., 2013) . CoRL maintain mesenchymal characteristics, whereas adult podocytes exhibit epithelial characteristics (Filipovic et al., 2017) . Therefore, for CoRL to serve as podocyte progenitors, they must undergo changes resembling a mesenchymal-to-epithelial transition (MET).
The transcription factor Wilms' tumor suppressor protein 1 (WT1) is required for podocyte development and homeostasis (Kann et al., 2015) . Missense mutations and conditionally deleting WT1 from podocytes leads to glomerular scarring in humans and mice (Pelletier et al., 1991; Gao et al., 2004; Chau et al., 2011) . WT1 is closely linked to the mesenchymal-epithelial balance in development and disease (Miller-Hodges and Hohenstein, 2012) , and the homeostasis of different cell types (Ozdemir and Hohenstein, 2014) , including the plasticity and cell fate of certain cells (Karki et al., 2014; Wen et al., 2016) . WT1 drives MET at the start of nephron development (Essafi et al., 2011; Berry et al., 2015) , although in the developing epicardium, WT1 controls the reverse, i.e., epithelial-tomesenchymal transition (Martinez-Estrada et al., 2010) . WT1 enhances proliferation and migration in certain cell types in a context-dependent manner (Wagner et al., 2008; Brett et al., 2013; Graziano et al., 2017) . Finally, WT1 and renin co-localize in a fraction of cells in the afferent arterioles. Moreover, WT1 (ÀKTS) can negatively modulate renin gene transcription through interaction at a binding site within the renin enhancer (Steege et al., 2008) .
These reports provided the rationale to test the hypothesis that WT1 is required for CoRL proliferation, migration, and transdifferentiation toward a podocyte fate in the context of podocyte depletion.
RESULTS

WT1 Expression Increases in Renin-Stained Cells Following Podocyte Depletion in Mice and Humans
We began by measuring the temporal expression of WT1 in renin-stained cells in the JGC in RenWt1 +/+ mice following podocyte depletion induced by the administration of a cytopathic anti-podocyte antibody. Following podocyte depletion, the percentage of renin cells co-staining for WT1 increased as follows ( Figures 1A-1F ): from a baseline to D3 of FSGS (6.16% ± 0.3% versus 14.5% ± 3.35%; p = 0.133; Figures 1A and 1B) , from baseline to D5 of FSGS (6.16% ± 0.3% versus 20.99% ± 2.20%; p = 0.001; Figures 1A and 1C) , from D5 to D14 of FSGS (20.99% ± 2.20% versus 33.63% ± 7.3%; p = 0.001; Figures 1C and 1D) , and from baseline to D28 of FSGS (6.16% ± 0.3% versus 26.5% ± 5.24%; p < 0.0001; Figures 1A and 1E ). Podocyte loss in podocyte TGFb-Receptor1 transgenic (PodTgfbr1) mice (Figures S1A-S1C) and membranous nephropathy rats (passive Heymann nephritis [PHN] model) (Figures S1D and S1E) was also accompanied by increased WT1 in renin-stained JGC cells. In contrast, WT1 was not detected in renin cells post uninephrectomy in mice, where absolute podocyte number remained normal ( Figure S1F ).
We confirmed the experimental results in human diseases. In normal human kidney, WT1 was mostly limited to podocytes (Figure 2A ). However, de novo WT1 was detected in renin-stained JGC cells in human FSGS ( Figure 2B ) and membranous nephropathy ( Figure 2C ). Similar results were obtained with different WT1 antibodies, and no staining was detected when the primary antibody was omitted (not shown).
These results show that WT1 protein increases in reninstained cells in the JGC in both experimental and human FSGS and membranous nephropathy in the context of podocyte loss. Figure S2B ), while renin mRNA levels were similar ( Figure S2C ). Cre was restricted to the JGC in mice containing the CreER transgene but not in Cre-negative mice (Figures S2D and S2E Staining for renin and Cre was not detected in glomerular cells in disease, consistent with CoRL migration to the glomerulus rather than ectopic renin expression in disease. These results were similar to our previous reports . Figures These results show that WT1 is critical for CoRL migration to the glomerulus following podocyte loss and their transdifferentiation. In the absence of WT1, enalapril has reduced efficacy on CoRL migration and transdifferentiation.
WT1 Is Important for CoRL Proliferation Following Podocyte Depletion
To test the role of WT1 in CoRL proliferation, bromodeoxyuridine (BrdU) was administered via intraperitoneal injections every 48 hr, starting at D2. Triple staining was performed for BrdU, WT1, and RFP to determine if proliferation was restricted to RFP + CoRL that co-expressed WT1, These results show that after podocyte depletion, the following occurs: (1) (Boyle et al., 2008; Kobayashi et al., 2008; Costantini and Kopan, 2010; Little and McMahon, 2012 Figures S6N and S6O ). In contrast, E-cadherin staining was not detected in the JGC in RenWt1 fl/fl mice following podocyte depletion, and enalapril had no effect ( Figures  S6Q and S6R) . These results show that following abrupt podocyte depletion, mesenchymal markers (MYH11, aSMA, SM22) decrease in CoRL, coincident with de novo staining for the epithelial cell markers cytokeratin 18 and E-cadherin (Figure S6S) Figure 7F ). The urinary albumin to creatinine ratio was also significantly higher in diseased RenWt1 fl/fl mice ( Figure 7K ). In summary, podocyte density was lower in RenWt1 fl/fl mice compared with RenWt1 +/+ mice, accompanied by higher glomerulosclerosis and albuminuria.
DISCUSSION
Adult podocytes cannot proliferate and are unable to selfrenew following depletion (Barisoni et al., 2000; Pavenstadt et al., 2003) . Their replacement in glomerular diseases is reliant on progenitors (Romagnani et al., 2013; Shankland et al., 2014) . CoRL plasticity has been reported in podocytes, PECs, kidney pericytes, and mesangial cells (Gomez et al., 2014; Pippin et al., 2015; Starke et al., 2015; Stefanska et al., 2016 We show that WT1 staining is detected in <5%-7% of renin-expressing cells in the JGC in normal mice and rats, and only occasionally in the JGC in normal human kidneys, similar to previous reports (Puelles et al., 2015) . The first major result of the studies was that following podocyte depletion in three experimental models, WT1 increased up to 5.5-fold from baseline in renin-expressing cells in the JGC. WT1 also increased in renin-expressing cells in human FSGS and membranous nephropathy. WT1 did not increase following uninephrectomy, serving as a negative control because podocyte number was unchanged.
The role for WT1 is well described in podocyte health (Ozdemir and Hohenstein, 2014; Mazzei and Manucha, 2016) , in non-kidney cell transdifferentiation (Ijpenberg et al., 2007) , and progenitor function (Martinez-Estrada et al., 2010; Bandiera et al., 2013) . To test the hypothesis that WT1 is necessary for CoRL to function as podocyte progenitors, we generated a transgenic mouse where WT1 was inducibly deleted specifically in CoRL. Under nonstressed conditions, deleting WT1 in CoRL had no impact on kidney or podocyte function and morphology.
CoRL migrate from the JGC to the glomerulus or tubulointerstitium during kidney development and in disease (Sequeira Lopez et al., 2004; Pippin et al., 2013 Pippin et al., , 2015 Starke et al., 2015; Zhang et al., 2015; Lichtnekert et al., 2016) . Here, RFP + CoRL were rarely detected in glomeruli of non-diseased RenWt1 +/+ and RenWt1 fl/fl mice. However, RFP + CoRL were readily detected in glomeruli in RenWt1 +/+ mice following podocyte depletion, similar to previous reports Lichtnekert et al., 2016) . The second major finding was that following podocyte depletion, RFP + CoRL were barely detected in glomeruli of RenWt1 fl/fl mice, and migration to the glomerulus was not augmented by enalapril in RenWt1 fl/fl mice.
These results are consistent with WT1 being necessary for CoRL migration and the enhanced migratory effects of enalapril. Similar results in the cancer field suggest that WT1 enhances cell invasion and migration (Jomgeow et al., 2006; Brett et al., 2013) . CoRL increase in the JGC following podocyte depletion , increased glomerular volume (Hodgin et al., 2015) , hypotension (Castellanos Rivera et al., 2011) , and following angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (Lichtnekert et al., 2016) . BrdU and Ki67 staining showed that following podocyte depletion in RenWt1 +/+ mice, RFP + CoRL proliferated, which was augmented by enalapril (Duim et al., 2015; Lichtnekert et al., 2016) . A third major finding was no increase in CoRL proliferation in RenWt1 fl/fl mice, and enalapril had no effect. This was of interest, as several groups have shown that WT1 enhances proliferation of tumor cells and cardiac endothelial cells Wu et al., 2015) . Like podocytes (Boyle et al., 2008; Kobayashi et al., 2008) , CoRL derive from mesenchymal origins (Sequeira Lopez et al., 2001; Matsushita et al., 2010; Wang et al., 2013; Ciampi et al., 2016) . To become podocytes, CoRL need to decrease mesenchymal proteins and acquire epithelial and podocyte proteins. At baseline, RFP + CoRL in the JGC in both RenWt1 +/+ and RenWt1 fl/fl mice express mesenchymal markers (MYH11, aSMA, SM22) but not epithelial markers (cytokeratin 18, E-cadherin). Following podocyte depletion in RenWt1 +/+ mice, RFP + CoRL in the JGC expressing these mesenchymal markers decreased significantly. This coincided with the de novo expression of cytokeratin 18 and E-cadherin. The MET-like changes in diseased RenWt1 +/+ mice were augmented by enalapril.
When in the glomerulus, a subset of CoRL co-expressed the podocyte markers p57, podocin, and synaptopodin. The fourth major finding was that following podocyte depletion in RenWt1 fl/fl mice, mesenchymal markers in RFP + CoRL did not decrease, nor did they begin to express epithelial markers, and enalapril had no impact. These findings are consistent with our previous reports on the importance of disruption of MET underlying the origin of Wilms' tumors (Berry et al., 2015; Hohenstein et al., 2015) , the role of Wt1 in this MET programming (Davies et al., 2004; Essafi et al., 2011) , and that loss of WT1 blocks MET in the cap mesenchyme (Essafi et al., 2011) .
The fifth major finding was that following abrupt podocyte loss, podocyte density remained lower in diseased RenWt1 fl/fl compared with diseased RenWt1 +/+ mice, accompanied by more glomerular scarring and albuminuria. We recognize that CoRL transdifferentiation alone is not sufficient to explain the differences, and other factors including different kidney progenitor populations need to be considered. Finally, our observation of intra-glomerular CoRL with coincident downregulation of renin expression would be consistent with the negative regulation previously described (Steege et al., 2008) . It will be of interest to assess the specific isoform(s) of WT1 expressed and retained in CoRL and the kinetics of renin downregulation and other cell differentiation features altered as a function of this interaction. In summary, WT1 expression in CoRL is important for the glomerular response to damage. When WT1 is selectively deleted in CoRL in the setting of podocyte loss, their proliferation and migration to the glomerulus, and to some extent their transdifferentiation toward a podocyte fate through MET changes, are markedly reduced. 
EXPERIMENTAL PROCEDURES
Experimental Models of Glomerular Disease Accompanied by Podocyte Depletion
The following experimental models of podocyte depletion were used:
(1) A cytotoxic sheep anti-glomerular antibody model of experimental FSGS was induced in RenWt1 fl/f and RenWt1 +/+ mice as previously described Lichtnekert et al., 2016) . On D3, when podocyte number was decreased by 30%-40%, mice were randomized into two groups: group 1 received drinking water; group 2 received the ACE inhibitor enalapril (75 mg/mL). Mice were killed on D28. Urine was collected at baseline, and on days 7, 14, and 28. Amersham Cell Proliferation Labeling Reagent (GE Healthcare Life Sciences, Little Chalfont, UK) was administered to quantitate cell proliferation . Urines were collected for albumin measurements by radial immunodiffusion assay (RID) (Marshall et al., 2011) ; urine creatinine was measured by colorimetric micro-plate assay (Cayman Chemical Company, Ann Arbor, MI).
(2) Podocyte TGFb-Receptor1 transgenic (PodTgfbr1) mice given doxycycline underwent TGFbR1-induced podocyte apoptosis and loss of 25% (D7) and 40% (D14), accompanied by glomerulosclerosis (Daehn et al., 2014) . (3) A PHN model of membranous nephropathy induced as previously described (Ohse et al., 2010) underwent progressive podocyte depletion (Petermann et al., 2003) . (4) A uninephrectomy model served as a negative control for podocyte depletion .
Human Glomerular Disease
Kidney biopsies from patients with FSGS and membranous nephropathy were obtained from the University of Chicago (UC). The study protocol was approved by the UC Institutional Review Board. Further details are described in Supplemental Experimental Procedures.
Laser Capture Microscopy and qRT-PCR RFP + CoRL were isolated by LCM, as described (Tretiakova and Hart, 2011) , with the Leica Laser Microdissection Systems LMD6500 and LMD7000 (Leica Microsystems Inc., Buffalo Grove, IL).
Immunoperoxidase and Immunofluorescent Staining
Formalin-fixed paraffin-embedded mouse, rat, and human kidney sections or frozen tissue sections (4-20 mm thick) were used. Following standard antigen retrieval steps, Avidin-biotin based, polymer-based, and fluorochrome-based staining was performed as previously described (Kimura et al., 1995; Wagner et al., 2014) . Further details are described in Supplemental Experimental Procedures.
Quantitative Analysis
Absolute numbers of renin measured on 150 ± 20 glomeruli per animal on p57/periodic acid-Schiff-stained sections (Zhang et al., 2015; Lichtnekert et al., 2016 
